us-abfm MCQ (SBA): Obesity Pharmacotherapy

Instant feedback + full explanation. One question, done properly.

EasyEndocrinologyObesity Pharmacotherapyus-abfmus-abim

A 63-year-old man with T2D and BMI 36 started semaglutide for obesity and glycemic control. What common adverse effect to counsel?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

us-abfm MCQ: Obesity Pharmacotherapy — Answer & Explanation | iatroX